Skip to main content
SpringerLink
Log in

Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Recently, it has been suggested that thyrotropin (TSH) concentration can be used as a marker for prediction of thyroid malignancy. In this study, we aimed to investigate the association between TSH levels and prediction of malignancy in euthyroid patients with different Bethesda categories. The data of 1433 euthyroid patients with 3206 thyroid nodules who underwent thyroidectomy were screened retrospectively. The preoperative cytology results, thyroid function tests, thyroid autoantibodies, and presence of histopathological Hashimoto’s thyroiditis (HT) were recorded. Of the 1433 patients, 585 (40.8 %) had malignant and 848 (59.2 %) had benign histopathology. Malignant group had smaller nodule size, elevated TSH levels, and higher rate of presence of HT compared to benign group (p < 0.001, all). Cytology results of 3206 nodules were as follows: 832 nondiagnostic (ND), 1666 benign, 392 atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS), 68 follicular neoplasm/suspicious for follicular neoplasm (FN/SFN), 133 suspicious for malignancy (SM), and 115 malignant. Both SM and malignant cytology groups had higher TSH levels than other 4 Bethesda categories (p < 0.05, all). Benign cytology group had significantly lower TSH levels compared to other cytology groups (p < 0.05, all). Patients with malignant final histopathology in ND and AUS/FLUS cytology groups had significantly higher TSH levels compared to patients with benign final histopathology (p < 0.05, all). Moreover, TSH levels showed to increase from Bethesda categories II to VI. In addition to cytology, higher TSH levels can be used as a supplementary marker in prediction of malignancy in certain Bethesda categories.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. E. Marqusee, C.B. Benson, M.C. Frates, P.M. Doubilet, P.R. Larsen, E.S. Cibas, S.J. Mandel, Usefulness of ultrasonography in the management of nodular thyroid disease. Ann. Intern. Med. 133(9), 696–700 (2000)

    Article  CAS  PubMed  Google Scholar 

  2. A. Belfiore, G.L. La Rosa, G.A. La Porta, D. Giuffrida, G. Milazzo, L. Lupo, C. Regalbuto, R. Vigneri, Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am. J. Med. 93(4), 363–369 (1992)

    Article  CAS  PubMed  Google Scholar 

  3. L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18), 2164–2167 (2006)

    Article  CAS  PubMed  Google Scholar 

  4. D. Danese, S. Sciacchitano, A. Farsetti, M. Andreoli, A. Pontecorvi, Diagnostic accuracy of conventional versus sonography-guided fineneedle aspiration biopsy of thyroid nodules. Thyroid 8(1), 15–21 (1998)

    Article  CAS  PubMed  Google Scholar 

  5. T. Yokozawa, A. Miyauchi, K. Kuma, M. Sugawara, Accurate and simple method of diagnosing thyroid nodules the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid 5(2), 141–145 (1995)

    Article  CAS  PubMed  Google Scholar 

  6. L. Yassa, E.S. Cibas, C.B. Benson, M.C. Frates, P.M. Doubilet, A. Gawande, F.D. Moore Jr, B.W. Kim, V. Nosé, E. Marqusee, P.R. Larsen, E.K. Alexander, Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 111(6), 508–516 (2007)

    Article  PubMed  Google Scholar 

  7. A.L. Maia, L.S. Ward, G.A. Carvalho, H. Graf, R.M. Maciel, L.M. Maciel, P.W. Rosario, M. Vaisman, Thyroid nodules and differentiated thyroid cancer: Brazilian consensus. Arq. Bras. Endocrinol. Metab. 51(5), 867–893 (2007)

    Article  Google Scholar 

  8. British Thyroid Association, Royal College of Physicians: British Thyroid Association Guidelines for the management of thyroid cancer, 2nd edn. (British Thyroid Association, London, 2007)

    Google Scholar 

  9. J.I. Lew, S.E. Rodgers, C.C. Solorzano, Developments in the use of ultrasound for thyroid cancer. Curr. Opin. Oncol. 22(1), 11–16 (2010)

    Article  PubMed  Google Scholar 

  10. L. Hegedus, Clinical practice. The thyroid nodule. N. Engl. J. Med. 351(17), 1764–1771 (2004)

    Article  PubMed  Google Scholar 

  11. G. Oler, J.M. Cerutti, High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Cancer 115(5), 972–980 (2009)

    Article  CAS  PubMed  Google Scholar 

  12. L. Hegedus, S.J. Bonnema, F.N. Bennedbaek, Management of simple nodular goiter: current status and future perspectives. Endocr. Rev. 24(1), 102–132 (2003)

    Article  PubMed  Google Scholar 

  13. K. Boelaert, J. Horacek, R.L. Holder, J.C. Watkinson, M.C. Sheppard, J.A. Franklyn, Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J. Clin. Endocrinol. Metab. 91(11), 4295–4301 (2006)

    Article  CAS  PubMed  Google Scholar 

  14. E. Fiore, T. Rago, M.A. Provenzale, M. Scutari, C. Ugolini, F. Basolo, G. Di Coscio, P. Miccoli, L. Grasso, A. Pinchera, P. Vitti, L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27,914 patients. Endocr. Relat. Cancer 17(1), 231–239 (2010)

    Article  CAS  PubMed  Google Scholar 

  15. K. Gul, D. Ozdemir, A. Dirikoc, A. Oguz, D. Tuzun, H. Baser, R. Ersoy, B. Cakir, Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin? Endocrine 37(2), 253–260 (2010)

    Article  CAS  PubMed  Google Scholar 

  16. M.R. Haymart, D.J. Repplinger, G.E. Leverson, D.F. Elson, R.S. Sippel, J.C. Jaume, H. Chen, Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J. Clin. Endocrinol. Metab. 93(3), 809–814 (2008)

    Article  CAS  PubMed  Google Scholar 

  17. E. Fiore, T. Rago, M.A. Provenzale, M. Scutari, C. Ugolini, F. Basolo, G. Di Coscio, P. Berti, L. Grasso, R. Elisei, A. Pinchera, P. Vitti, Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr. Relat. Cancer 16(4), 1251–1260 (2009)

    Article  CAS  PubMed  Google Scholar 

  18. E.S. Cibas, S.Z. Ali, NCI Thyoid FNA State of the Science Conference, The Bethesda System for reporting thyroid cytopathology. Am. J. Clin. Pathol. 132(5), 658–665 (2009)

    Article  PubMed  Google Scholar 

  19. Y.J. Choi, I. Jung, S.J. Min, H.J. Kim, J.H. Kim, S. Kim, J.S. Park, J.H. Shin, Y.M. Sohn, J.H. Yoon, J.Y. Kwak, Thyroid nodule with benign cytology: is clinical follow-up enough? PLoS One 8(5), e63834 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. J.Y. Kwak, E.K. Kim, H.J. Kim, M.J. Kim, E.J. Son, H.J. Moon, How to combine ultrasound and cytological information in decision making about thyroid nodules. Eur. Radiol. 19(8), 1923–1931 (2009)

    Article  PubMed  Google Scholar 

  21. J.Y. Kwak, H. Koo, J.H. Youk, M.J. Kim, H.J. Moon, E.J. Son, E.K. Kim, Value of US correlation of a thyroid nodule with initially benign cytologic results. Radiology 254(1), 292–300 (2010)

    Article  PubMed  Google Scholar 

  22. J.H. Yoon, H.J. Moon, E.K. Kim, J.Y. Kwak, Inadequate cytology in thyroid nodules: should we repeat aspiration or follow-up? Ann. Surg. Oncol. 18(5), 1282–1289 (2011)

    Article  PubMed  Google Scholar 

  23. S.W. Lee, H.J. Lee, H.J. Kim, J. Lee, J.Y. Park, S.H. Kim, J. Kim, Combined categorical reporting systems of US and cytology findings for thyroid nodules: guidance on repeat fine-needle aspiration cytology. Radiology 266(3), 956–963 (2013)

    Article  PubMed  Google Scholar 

  24. V.Y. Jo, E.B. Stelow, S.M. Dustin, K.Z. Hanley, Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am. J. Clin. Pathol. 134(3), 450–456 (2010)

    Article  PubMed  Google Scholar 

  25. C.Y. Eng, M.S. Quraishi, P.J. Bradley, Management of Thyroid nodules in adult patients. Head Neck Oncology 2, 11 (2010)

    Article  PubMed  PubMed Central  Google Scholar 

  26. S.J. Mandel, A 64-year-old woman with a thyroid nodule. JAMA 292(21), 2632–2642 (2004)

    Article  CAS  PubMed  Google Scholar 

  27. M.R. Castro, R.P. Espiritu, R.S. Bahn, M.R. Henry, H. Gharib, P.J. Caraballo, J.C. Morris, Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid 21(11), 1191–1198 (2011)

    Article  PubMed  PubMed Central  Google Scholar 

  28. E.S. Kim, D.J. Lim, K.H. Baek, J.M. Lee, M.K. Kim, H.S. Kwon, K.H. Song, M.I. Kang, B.Y. Cha, K.W. Lee, H.Y. Son, Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 20(8), 885–891 (2010)

    Article  CAS  PubMed  Google Scholar 

  29. F. Grob, J. Deladoey, L. Legault, L. Spigelblatt, A. Fournier, G. Vassart, G. Van Vliet, Autonomous adenomas caused by somatic mutations of the thyroid-stimulating hormone receptor in children. Horm. Res. Paediatr. 81(2), 73–79 (2014)

    Article  CAS  PubMed  Google Scholar 

  30. T.F. Davies, T. Ando, R.Y. Lin, Y. Tomer, R. Latif, Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J. Clin. Invest. 115(8), 1972–1983 (2005)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. H. He, W. Li, S. Liyanarachchi, J. Jendrzejewski, M. Srinivas, R.V. Davuluri, R. Nagy, A. de la Chapelle, Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR and a novel lincRNA gene, PTCSC2. J. Clin. Endocrinol. Metab. 100(1), 164–172 (2015)

    Article  Google Scholar 

  32. M.S. Khan, A.A. Pandith, S.R. Masoodi, K.A. Wani, M. Ul, Hussain, S. Mudassar, Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status. Endocrine 47(2), 449–455 (2014)

    Article  CAS  PubMed  Google Scholar 

  33. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. Mclver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009)

    Article  PubMed  Google Scholar 

  34. G. Brabant, C. Maenhaut, J. Kohrle, G. Scheumann, H. Dralle, C. Hoang-Vu, R.D. Hesch, A. von zur Mühlen, G. Vassart, J.E. Dumont, Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol. Cell. Endocrinol. 82(1), 7–12 (1991)

    Article  Google Scholar 

  35. M. D’Agostino, M. Sponziello, C. Puppin, M. Celano, V. Maggisano, F. Baldan, M. Biffoni, S. Bulotta, C. Durante, S. Filetti, G. Damante, D. Russo, Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. J. Mol. Endocrinol. 52(2), 121–131 (2014)

    Article  PubMed  Google Scholar 

  36. J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, J.G. Jonasson, A. Sigurdsson, J.T. Bergthorsson, H. He, T. Blondal, F. Geller, M. Jakobsdottir, D.N. Magnusdottir, S. Matthiasdottir, S.N. Stacey, O.B. Skarphedinsson, H. Helgadottir, W. Li, R. Nagy, E. Aguillo, E. Faure, E. Prats, B. Saez, M. Martinez, G.I. Eyjolfsson, U.S. Bjornsdottir, H. Holm, K. Kristjansson, M.L. Frigge, H. Kristvinsson, J.R. Gulcher, T. Jansson, T. Rafnar, H. Hjartarsson, J.I. Mayordomo, A. de la Chapelle, J. Hrafnkelsson, U. Thorsteinsdottir, A. Kong, K. Stefansson, Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet. 41(4), 460–464 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, J.G. Jonasson, G. Masson, H. He, A. Jonasdottir, A. Sigurdsson, S.N. Stacey, H. Johannsdottir, H.T. Helgadottir, W. Li, R. Nagy, M.D. Ringel, R.T. Kloos, M.C. de Visser, T.S. Plantinga, M. den Heijer, E. Aguillo, A. Panadero, E. Prats, A. Garcia-Castano, A. De Juan, F. Rivera, G.B. Walters, H. Bjarnason, L. Tryggvadottir, G.I. Eyjolfsson, U.S. Bjornsdottir, H. Holm, I. Olafsson, K. Kristjansson, H. Kristvinsson, O.T. Magnusson, G. Thorleifsson, J.R. Gulcher, A. Kong, L.A. Kiemeney, T. Jonsson, H. Hjartarson, J.I. Mayordomo, R.T. Netea-Maier, A. de la Chapelle, J. Hrafnkelsson, U. Thorsteinsdottir, T. Rafnar, K. Stefansson, Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat. Genet. 44(3), 319–322 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. F. Furuya, H. Ying, L. Zhao, S.Y. Cheng, Novel functions of thyroid hormone receptor mutants: beyond nucleus-initiated transcription. Steroids 72(2), 171–179 (2007)

    Article  CAS  PubMed  Google Scholar 

  39. J. Jonklaas, H. Nsouli-Maktabi, S.J. Soldin, Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 18(9), 943–952 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. S. Rinaldi, M. Plummer, C. Biessy, K.K. Tsilidis, J.N. Østergaard, K. Overvad, A. Tjonneland, J. Halkjaer, M.C. Boutron-Ruault, F. Clavel-Chapelon, L. Dossus, R. Kaaks, A. Lukanova, H. Boeing, A. Trichopoulou, P. Lagiou, D. Trichopoulod, D. Palli, C. Agnoli, R. Tumino, P. Vineis, S. Panico, H.B. Bueno-de-Mesquita, P.H. Peeters, E. Weiderpass, E. Lund, J.R. Quiros, A. Agudo, E. Molina, N. Larranaga, C. Navarro, E. Ardanaz, J. Manjer, M. Almquist, M. Sandström, J. Hennings, K.T. Khaw, J. Schmidt, R.C. Travis, G. Byrnes, A. Scalbert, I. Romieu, M. Gunter, E. Riboli, S. Franceschi, Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J. Natl. Cancer. Inst. 106(6), dju097 (2014)

    Article  PubMed  Google Scholar 

  41. F.F. Maia, P.S. Matos, E.J. Pavin, D.E. Zantut-Wittmann, Thyroid imaging reporting and data system score combined with Bethesda system for malignancy risk stratification in thyroid nodules with indeterminate results on cytology. Clin. Endocrinol. 82(3), 439–444 (2015)

    Article  Google Scholar 

  42. T.G. Strieder, M.F. Prummel, J.G. Tijssen, E. Endert, W.M. Wiersinga, Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin. Endocrinol. 59(3), 396–401 (2003)

    Article  Google Scholar 

  43. M.R. Haymart, S.L. Glinberg, J. Liu, R.S. Sippel, J.C. Jaume, H. Chen, Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin. Endocrinol. 71(3), 434–439 (2009)

    Article  CAS  Google Scholar 

  44. M.E. Dailey, S. Lindsay, R. Skahen, Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch. Surg. 70(2), 291–297 (1955)

    Article  CAS  PubMed  Google Scholar 

  45. T. Rago, G. Di Coscio, C. Ugolini, M. Scutari, F. Basolo, F. Latrofa, R. Romani, P. Berti, L. Grasso, L.E. Braverman, A. Pinchera, P. Vitti, Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin. Endocrinol. 67(3), 363–369 (2007)

    Article  CAS  Google Scholar 

  46. F. Boi, M.L. Lai, B. Marziani, L. Minerba, G. Faa, S. Mariotti, High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur. J. Endocrinol. 153(5), 637–642 (2005)

    Article  CAS  PubMed  Google Scholar 

  47. B. Corvilain, The natural history of thyroid autonomy and hot nodules. Ann. Endocrinol. 64(1), 17–22 (2003)

    CAS  Google Scholar 

  48. G. Treglia, P. Trimboli, F.A. Verburg, M. Luster, L. Giovanella, Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule. Eur. J. Clin. Invest. 45(7), 739–744 (2015)

    Article  CAS  PubMed  Google Scholar 

  49. R. Chami, R. Moreno-Reyes, B. Corvilain, TSH measurement is not an appropriate screening test for autonomous functioning thyroid nodules: a retrospective study of 368 patients. Eur. J. Endocrinol. 170(4), 593–599 (2014)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Ataturk Education and Research Hospital, Ovecler, 1297 Sokak, No: 1/22, 06460, Ankara, Turkey

    Husniye Baser & Berna Evranos

  2. Department of Endocrinology and Metabolism, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey

    Oya Topaloglu, Abbas Ali Tam, Reyhan Ersoy & Bekir Cakir

  3. Department of Biostatistics, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey

    Afra Alkan

  4. Department of Pathology, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey

    Nuran Sungu

  5. Department of General Surgery, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey

    Ersin Gurkan Dumlu

Authors
  1. Husniye Baser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oya Topaloglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abbas Ali Tam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Berna Evranos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Afra Alkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nuran Sungu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ersin Gurkan Dumlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Reyhan Ersoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bekir Cakir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Husniye Baser.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baser, H., Topaloglu, O., Tam, A.A. et al. Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system. Endocrine 53, 520–529 (2016). https://doi.org/10.1007/s12020-016-0919-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-0919-4

Keywords

Search

Navigation